Evommune, Inc. (EVMN)

13.75 +0.08 (+0.59%) USD  |  NYSE  |  Aug 25, 15:41
More

Evommune Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for EVMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to . Start Trial.
Date Value

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
MapLight Therapeutics, Inc. Upgrade
Mineralys Therapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade